1. Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment 
Jonathan Pearson-Stuttard, BMBCh, Bin Zhou, MSc, Vasilis Kontis, PhD, James Bentham, PhD, Marc J Gunter, PhD, Prof Majid Ezzati, FMed Sci 
The Lancet Diabetes & Endocrinology 
Volume 6, Issue 2, Pages (February 2018)
DOI: /S (17)
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

2. Figure 1
Global cancer cases in 2012 attributable to diabetes and high BMI, individually and combined, in the conservative and independent scenarios, by region
BMI=body-mass index.
The Lancet Diabetes & Endocrinology 2018 6, DOI: ( /S (17) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

3. Figure 2 Global site-specific cancer cases in 2012
Cases by (A) diabetes and high BMI, individually and in combination, in the conservative and independent scenarios and (B) region, in the combined independent scenario. BMI=body-mass index.
The Lancet Diabetes & Endocrinology 2018 6, DOI: ( /S (17) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

4. Figure 3
Population attributable fraction of all cancer incidence in 2012
Population attributable fractions shown are those of (A) diabetes, (B) high BMI, and (C) diabetes and high BMI combined as independent risks. Countries shown in grey did not have cancer incidence data. BMI=body-mass index.
The Lancet Diabetes & Endocrinology 2018 6, DOI: ( /S (17) )
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions